Foghorn Therapeutics's total assets for Q1 2025 were $258.69M, a decrease of -8.91% from the previous quarter. FHTX total liabilities were $320.34M for the fiscal quarter, a -2.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.